Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
What Is the Growth Outlook for the GLP-1 Obesity Home Delivery Injectables Market by Country
By mimicking the natural hormone, it helps people eat less and lose weight
Cardiovascular Benefits of GLP-1 Medications Multiple large-scale cardiovascular outcome trials (CVOTs) have demonstrated that certain GLP-1 drugs reduce the risk of major adverse cardiac events (MACE) in high-risk patients: The SELECT trial result is particularly significant: it was the first to show cardiovascular protection from a weight loss drug in patients without diabetes expanding the potential use of semaglutide far beyond its original indication
In addition, Livarise Injection (3ml Cartridge +10 Needles) is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring
64% of large firms say GLP-1 drug coverage moderately or significantly impacted their prescription drug spending Similar to the findings on use, 43% of firms with 1,000 to 4,999 workers, and 66% of firms with 5,000 or more workers, say that covering GLP-1 agonists for weight loss had a significant impact on the health plans prescription drug spending
US$ 29.57
US$ 26.23
US$ 25.41
US$ 28.89
US$ 21.96
US$ 23.58
